You are here » Home » Company » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 24 May 394.55 -8.85
(-2.19%)
OPEN

404.00

HIGH

406.95

LOW

392.70

NSE 00:00 | 24 May 394.95 -9.20
(-2.28%)
OPEN

405.00

HIGH

406.90

LOW

392.65

OPEN 404.00
PREVIOUS CLOSE 403.40
VOLUME 21356
52-Week high 690.60
52-Week low 386.30
P/E 6.31
Mkt Cap.(Rs cr) 11,134
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 404.00
CLOSE 403.40
VOLUME 21356
52-Week high 690.60
52-Week low 386.30
P/E 6.31
Mkt Cap.(Rs cr) 11,134
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd was incorporated in November 18th 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   11,134
EPS - TTM () [*S] 62.55
P/E Ratio (X) [*S] 6.31
Face Value ()   1
Latest Dividend (%)   250.00
Latest Dividend Date 08 Sep 2021
Dividend Yield (%) 0.63
Book Value / Share () [*S] 566.44
P/B Ratio () [*S] 0.70
[*C] Consolidated     [*S] Standalone    

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Dec 2021 Dec 2020 % Chg
Net Sales 2033.05 2786.77 -27.05
Other Income 216.74 28.51 660.22
Total Income 2249.8 2815.27 -20.09
Total Expenses 1522.57 2256.69 -32.53
Operating Profit 727.23 558.58 30.19
Net Profit 548.52 248.18 121.02
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Suven Pharma 521.95 0.59 13288.85
Natco Pharma 687.05 -2.53 12542.10
J B Chem & Pharm 1571.70 0.02 12149.24
Glenmark Pharma. 394.55 -2.19 11134.20
ERIS Lifescience 678.55 -4.62 9228.28
Anupam Rasayan 759.35 -0.04 7614.00
P & G Health Ltd 4350.60 -0.45 7222.00
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.65
Banks/FIs 0.44
FIIs 24.12
Insurance 0.00
Mutual Funds 6.18
Indian Public 15.88
Custodians 0.00
Other 2.39
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
25/06/2021 Nirmal Bang Not Rated 639 PDF IconDetails
19/08/2020 Nirmal Bang Accumulate 481 PDF IconDetails
19/08/2020 Elara Capital Accumulate 481 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -1.91% -1.85% -0.49% -0.83%
1 Month -11.03% -10.96% -5.50% -6.10%
3 Month -8.20% -8.11% -0.88% -0.76%
6 Month -24.10% -24.01% -7.35% -7.41%
1 Year -34.79% -34.72% 6.71% 6.10%
3 Year -29.42% -29.35% 37.07% 36.15%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 392.70
406.95
Week Low/High 386.30
410.00
Month Low/High 386.30
456.00
YEAR Low/High 386.30
691.00
All TIME Low/High 1.89
1262.00
.